The global Fluorescence-Guided Surgery Systems market size is predicted to grow from US$ 148 million in 2025 to US$ 428 million in 2031; it is expected to grow at a CAGR of 19.4% from 2025 to 2031.
Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.
The fluorescence-guided surgery (FGS) systems market is primarily driven by the growing demand for more precise and minimally invasive surgical procedures. FGS systems enable surgeons to identify tumors, blood vessels, and other critical structures with high accuracy using fluorescent markers, improving surgical outcomes and reducing complications. The increasing prevalence of cancer worldwide is a key driver, as fluorescence-guided surgery is particularly beneficial in oncology for tumor delineation and complete excision. Additionally, advancements in fluorescence imaging technology, such as higher resolution and improved sensitivity, along with the adoption of robotic-assisted surgeries, further propel market growth. As patients and healthcare providers demand safer, more effective treatments, the market for FGS systems is expected to continue expanding.
However, the market also faces several challenges. One of the primary hurdles is the high cost of fluorescence-guided surgery systems, which can be a barrier to adoption, particularly in low-resource healthcare settings. Additionally, the technology requires specialized training for medical professionals to ensure its proper use, which adds to the operational complexity and costs. The regulatory approval process for fluorescence-based imaging agents can also be lengthy and costly, delaying the introduction of new treatments and technologies. Moreover, the integration of fluorescence-guided surgery systems with existing medical devices and hospital infrastructure can be challenging, limiting their widespread implementation, especially in smaller or less-equipped healthcare facilities.
Global key players of Fluorescence-Guided Surgery Systems include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu and Fluoptics, etc. Top two players occupy for a share about 70%. North America is the largest market, with a share about 63%, followed by Europe and China.
The 鈥淔luorescence-Guided Surgery Systems Industry Forecast鈥� looks at past sales and reviews total world Fluorescence-Guided Surgery Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Fluorescence-Guided Surgery Systems sales for 2025 through 2031. With Fluorescence-Guided Surgery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fluorescence-Guided Surgery Systems industry.
This Insight Report provides a comprehensive analysis of the global Fluorescence-Guided Surgery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fluorescence-Guided Surgery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Fluorescence-Guided Surgery Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fluorescence-Guided Surgery Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fluorescence-Guided Surgery Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Fluorescence-Guided Surgery Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Only for Open Surgery
System for Endoscopy
Segmentation by Application:
Cancer Surgeries
Cardiovascular Surgeries
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Stryker
Hamamatsu Photonics
Medtronic
Quest Medical Imaging
Shimadzu
Fluoptics
KARL STORZ
Richard Wolf
OptoMedic
Mindray
Olympus
Key Questions Addressed in this Report
What is the 10-year outlook for the global Fluorescence-Guided Surgery Systems market?
What factors are driving Fluorescence-Guided Surgery Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fluorescence-Guided Surgery Systems market opportunities vary by end market size?
How does Fluorescence-Guided Surgery Systems break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fluorescence-Guided Surgery Systems Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Fluorescence-Guided Surgery Systems by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Fluorescence-Guided Surgery Systems by Country/Region, 2020, 2024 & 2031
2.2 Fluorescence-Guided Surgery Systems Segment by Type
2.2.1 Only for Open Surgery
2.2.2 System for Endoscopy
2.3 Fluorescence-Guided Surgery Systems Sales by Type
2.3.1 Global Fluorescence-Guided Surgery Systems Sales Market Share by Type (2020-2025)
2.3.2 Global Fluorescence-Guided Surgery Systems Revenue and Market Share by Type (2020-2025)
2.3.3 Global Fluorescence-Guided Surgery Systems Sale Price by Type (2020-2025)
2.4 Fluorescence-Guided Surgery Systems Segment by Application
2.4.1 Cancer Surgeries
2.4.2 Cardiovascular Surgeries
2.4.3 Others
2.5 Fluorescence-Guided Surgery Systems Sales by Application
2.5.1 Global Fluorescence-Guided Surgery Systems Sale Market Share by Application (2020-2025)
2.5.2 Global Fluorescence-Guided Surgery Systems Revenue and Market Share by Application (2020-2025)
2.5.3 Global Fluorescence-Guided Surgery Systems Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Fluorescence-Guided Surgery Systems Breakdown Data by Company
3.1.1 Global Fluorescence-Guided Surgery Systems Annual Sales by Company (2020-2025)
3.1.2 Global Fluorescence-Guided Surgery Systems Sales Market Share by Company (2020-2025)
3.2 Global Fluorescence-Guided Surgery Systems Annual Revenue by Company (2020-2025)
3.2.1 Global Fluorescence-Guided Surgery Systems Revenue by Company (2020-2025)
3.2.2 Global Fluorescence-Guided Surgery Systems Revenue Market Share by Company (2020-2025)
3.3 Global Fluorescence-Guided Surgery Systems Sale Price by Company
3.4 Key Manufacturers Fluorescence-Guided Surgery Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fluorescence-Guided Surgery Systems Product Location Distribution
3.4.2 Players Fluorescence-Guided Surgery Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Fluorescence-Guided Surgery Systems by Geographic Region
4.1 World Historic Fluorescence-Guided Surgery Systems Market Size by Geographic Region (2020-2025)
4.1.1 Global Fluorescence-Guided Surgery Systems Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Fluorescence-Guided Surgery Systems Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Fluorescence-Guided Surgery Systems Market Size by Country/Region (2020-2025)
4.2.1 Global Fluorescence-Guided Surgery Systems Annual Sales by Country/Region (2020-2025)
4.2.2 Global Fluorescence-Guided Surgery Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Fluorescence-Guided Surgery Systems Sales Growth
4.4 APAC Fluorescence-Guided Surgery Systems Sales Growth
4.5 Europe Fluorescence-Guided Surgery Systems Sales Growth
4.6 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Growth
5 Americas
5.1 Americas Fluorescence-Guided Surgery Systems Sales by Country
5.1.1 Americas Fluorescence-Guided Surgery Systems Sales by Country (2020-2025)
5.1.2 Americas Fluorescence-Guided Surgery Systems Revenue by Country (2020-2025)
5.2 Americas Fluorescence-Guided Surgery Systems Sales by Type (2020-2025)
5.3 Americas Fluorescence-Guided Surgery Systems Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fluorescence-Guided Surgery Systems Sales by Region
6.1.1 APAC Fluorescence-Guided Surgery Systems Sales by Region (2020-2025)
6.1.2 APAC Fluorescence-Guided Surgery Systems Revenue by Region (2020-2025)
6.2 APAC Fluorescence-Guided Surgery Systems Sales by Type (2020-2025)
6.3 APAC Fluorescence-Guided Surgery Systems Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fluorescence-Guided Surgery Systems by Country
7.1.1 Europe Fluorescence-Guided Surgery Systems Sales by Country (2020-2025)
7.1.2 Europe Fluorescence-Guided Surgery Systems Revenue by Country (2020-2025)
7.2 Europe Fluorescence-Guided Surgery Systems Sales by Type (2020-2025)
7.3 Europe Fluorescence-Guided Surgery Systems Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fluorescence-Guided Surgery Systems by Country
8.1.1 Middle East & Africa Fluorescence-Guided Surgery Systems Sales by Country (2020-2025)
8.1.2 Middle East & Africa Fluorescence-Guided Surgery Systems Revenue by Country (2020-2025)
8.2 Middle East & Africa Fluorescence-Guided Surgery Systems Sales by Type (2020-2025)
8.3 Middle East & Africa Fluorescence-Guided Surgery Systems Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fluorescence-Guided Surgery Systems
10.3 Manufacturing Process Analysis of Fluorescence-Guided Surgery Systems
10.4 Industry Chain Structure of Fluorescence-Guided Surgery Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fluorescence-Guided Surgery Systems Distributors
11.3 Fluorescence-Guided Surgery Systems Customer
12 World Forecast Review for Fluorescence-Guided Surgery Systems by Geographic Region
12.1 Global Fluorescence-Guided Surgery Systems Market Size Forecast by Region
12.1.1 Global Fluorescence-Guided Surgery Systems Forecast by Region (2026-2031)
12.1.2 Global Fluorescence-Guided Surgery Systems Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Fluorescence-Guided Surgery Systems Forecast by Type (2026-2031)
12.7 Global Fluorescence-Guided Surgery Systems Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Stryker
13.1.1 Stryker Company Information
13.1.2 Stryker Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.1.3 Stryker Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Stryker Main Business Overview
13.1.5 Stryker Latest Developments
13.2 Hamamatsu Photonics
13.2.1 Hamamatsu Photonics Company Information
13.2.2 Hamamatsu Photonics Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.2.3 Hamamatsu Photonics Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hamamatsu Photonics Main Business Overview
13.2.5 Hamamatsu Photonics Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.3.3 Medtronic Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Quest Medical Imaging
13.4.1 Quest Medical Imaging Company Information
13.4.2 Quest Medical Imaging Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.4.3 Quest Medical Imaging Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Quest Medical Imaging Main Business Overview
13.4.5 Quest Medical Imaging Latest Developments
13.5 Shimadzu
13.5.1 Shimadzu Company Information
13.5.2 Shimadzu Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.5.3 Shimadzu Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shimadzu Main Business Overview
13.5.5 Shimadzu Latest Developments
13.6 Fluoptics
13.6.1 Fluoptics Company Information
13.6.2 Fluoptics Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.6.3 Fluoptics Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Fluoptics Main Business Overview
13.6.5 Fluoptics Latest Developments
13.7 KARL STORZ
13.7.1 KARL STORZ Company Information
13.7.2 KARL STORZ Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.7.3 KARL STORZ Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 KARL STORZ Main Business Overview
13.7.5 KARL STORZ Latest Developments
13.8 Richard Wolf
13.8.1 Richard Wolf Company Information
13.8.2 Richard Wolf Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.8.3 Richard Wolf Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Richard Wolf Main Business Overview
13.8.5 Richard Wolf Latest Developments
13.9 OptoMedic
13.9.1 OptoMedic Company Information
13.9.2 OptoMedic Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.9.3 OptoMedic Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 OptoMedic Main Business Overview
13.9.5 OptoMedic Latest Developments
13.10 Mindray
13.10.1 Mindray Company Information
13.10.2 Mindray Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.10.3 Mindray Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mindray Main Business Overview
13.10.5 Mindray Latest Developments
13.11 Olympus
13.11.1 Olympus Company Information
13.11.2 Olympus Fluorescence-Guided Surgery Systems Product Portfolios and Specifications
13.11.3 Olympus Fluorescence-Guided Surgery Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Olympus Main Business Overview
13.11.5 Olympus Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
